Sec Form 5 Filing - Lobetti Charles Burns III @ Healthcare Integrated Technologies Inc. - 2024-07-31

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Lobetti Charles Burns III
2. Issuer Name and Ticker or Trading Symbol
Healthcare Integrated Technologies Inc. [ HITC]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Chief Financial Officer
(Last) (First) (Middle)
814 EVOLVE WAY APT 108
3. Date of Earliest Transaction (MM/DD/YY)
07/31/2024
(Street)
KNOXVILLE, TN37915
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/16/2020 A( 1 ) 500,000 A $ 0.06 500,000 D
Common Stock 07/31/2023 A( 2 ) 1,500,000 A $ 0.11 1,500,000 D
Common Stock 07/31/2024 A( 3 ) 2,028,764 A $ 0.1 2,028,764 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Holdings $ 0.15 ( 4 ) 10/08/2019 10/07/2024 Common Stock 150,000 150,000 D
Holdings $ 0.15 ( 4 ) 10/08/2020 10/07/2024 Common Stock 150,000 150,000 D
Holdings $ 0.15 ( 4 ) 10/08/2021 10/07/2024 Common Stock 150,000 150,000 D
Holdings $ 0.15 ( 4 ) 10/08/2022 10/07/2024 Common Stock 150,000 150,000 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Lobetti Charles Burns III
814 EVOLVE WAY APT 108
KNOXVILLE, TN37915
Chief Financial Officer
Signatures
/s/ Charles B. Lobetti, III 08/02/2024
Signature of Reporting Person Date
Explanation of Responses:
( 1 )On July 16, 2020, the Board of Directors of the issuer awarded the Reporting Person 600,000 shares of restricted common stock, all of which are currently vested. The shares vested as follows: 7/16/20 - 200,000 shares; 7/16/21 - 100,000 shares; 7/16/22 - 100,000 shares; and 7/16/23 - 100,000 shares.
( 2 )On July 31, 2023, the Board of Directors of the issuer approved the issuance of 1,500,000 shares of common stock to the Reporting Person as partial payment for compensation owed to him as of July 31, 2023 under his Employment Agreement dated October 8, 2019.
( 3 )On July 31, 2024, the Board of Directors of the issuer approved the issuance of 2,028,764 shares of common stock to the Reporting Person as partial payment for compensation owed to him as of July 31, 2024 under his Employment Agreement dated January 31, 2024.
( 4 )On October 8, 2019, the Reporting Person was appointed Chief Financial Officer of the issuer. Upon execution of an Employment Agreement dated on such date, the Reporting Person was awarded 600,000 common stock purchase options, all of which are currently vested. The common stock purchase options vested as follows: 10/8/19 - 150,000 shares; 10/8/20 - 150,000 shares; 10/8/21 - 150,000 shares; and 10/8/22 - 150,000.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.